Published in J Thorac Cardiovasc Surg on August 24, 2012
Antegrade versus retrograde cerebral perfusion for hemiarch replacement with deep hypothermic circulatory arrest: does it matter? A propensity-matched analysis. J Thorac Cardiovasc Surg (2014) 1.51
Retracted How to Perfuse: Concepts of Cerebral Protection during Arch Replacement. Biomed Res Int (2015) 1.38
A meta-analysis of deep hypothermic circulatory arrest versus moderate hypothermic circulatory arrest with selective antegrade cerebral perfusion. Ann Cardiothorac Surg (2013) 1.19
Open and closed distal anastomosis for acute type A aortic dissection repair. Interact Cardiovasc Thorac Surg (2016) 0.76
Comparison between antegrade and retrograde cerebral perfusion or profound hypothermia as brain protection strategies during repair of type A aortic dissection. Ann Cardiothorac Surg (2016) 0.75
Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet (2009) 5.16
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ (2014) 2.62
Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke (2006) 2.31
The ARCH Projects: design and rationale (IAASSG 001). Eur J Cardiothorac Surg (2013) 2.06
Novel insights into the mechanisms and treatment of intramural hematoma affecting the entire thoracic aorta. Ann Thorac Surg (2008) 1.76
Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts. Ann Thorac Surg (2004) 1.70
2014 ESC/EACTS guidelines on myocardial revascularization. Rev Esp Cardiol (Engl Ed) (2015) 1.69
Prolonged extracorporeal membrane oxygenation-assisted support provides improved survival in hypothermic patients with cardiocirculatory arrest. J Thorac Cardiovasc Surg (2007) 1.52
Value of transesophageal 3D echocardiography as an adjunct to conventional 2D imaging in preoperative evaluation of cardiac masses. Echocardiography (2008) 1.50
Increased mortality and perioperative complications in patients with previous elective percutaneous coronary interventions undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg (2009) 1.46
Co-infection with two Chlamydophila species in a case of fulminant myocarditis. Crit Care Med (2007) 1.43
Endovascular stent-graft placement of aneurysms involving the descending aorta originating from chronic type B dissections. Ann Thorac Surg (2007) 1.43
Effect on false-lumen status of a combined vascular and endovascular approach for the treatment of acute type A aortic dissection. Eur J Cardiothorac Surg (2011) 1.43
One-year outcomes of the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON) trial: a prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve System. J Thorac Cardiovasc Surg (2012) 1.43
Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arterioscler Thromb Vasc Biol (2009) 1.40
Effect of cytomegalovirus immunoglobulin on the incidence of lymphoproliferative disease after lung transplantation: single-center experience with 1157 patients. Transplantation (2013) 1.39
Evaluation of cardiac scoring models for an Austrian cardiac register. Interact Cardiovasc Thorac Surg (2007) 1.39
Impact of Rabbit Antithymocyte Globulin Dose on Long-term Outcomes in Heart Transplant Patients. Transplantation (2016) 1.38
Propensity score-matched analysis of aortic valve replacement by mini-thoracotomy. J Heart Valve Dis (2010) 1.35
Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX. Ann Surg Oncol (2010) 1.32
Mechanisms of failure and outcome of secondary surgical interventions after thoracic endovascular aortic repair (TEVAR). Ann Thorac Surg (2011) 1.24
Quality of life after lung transplantation: a cross-sectional study. J Heart Lung Transplant (2005) 1.19
Ursolic acid causes DNA-damage, p53-mediated, mitochondria- and caspase-dependent human endothelial cell apoptosis, and accelerates atherosclerotic plaque formation in vivo. Atherosclerosis (2011) 1.18
Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia. J Biol Chem (2005) 1.13
Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation. Transplantation (2006) 1.12
2014 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention (2015) 1.08
Results of endovascular repair of the thoracic aorta with the Talent Thoracic stent graft: the Talent Thoracic Retrospective Registry. J Thorac Cardiovasc Surg (2006) 1.08
Supra-aortic transposition for combined vascular and endovascular repair of aortic arch pathology. Ann Thorac Surg (2008) 1.07
VEGF-A and -C but not -B mediate increased vascular permeability in preserved lung grafts. Transplantation (2002) 1.04
Impaired target site penetration of vancomycin in diabetic patients following cardiac surgery. Antimicrob Agents Chemother (2006) 1.00
Stent-graft placement in atherosclerotic descending thoracic aortic aneurysms: midterm results. J Endovasc Ther (2004) 0.99
Treatment of symptomatic coral reef aorta by endovascular stent-graft placement. Ann Thorac Surg (2008) 0.99
Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation. Ann Thorac Surg (2004) 0.97
Cardiac hepatopathy before and after heart transplantation. Transpl Int (2005) 0.96
Characteristics of TAV- and BAV-associated thoracic aortic aneurysms--smooth muscle cell biology, expression profiling, and histological analyses. Atherosclerosis (2011) 0.95
Non-toxic cadmium concentrations induce vascular inflammation and promote atherosclerosis. Circ J (2011) 0.94
B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression. Hum Immunol (2002) 0.94
Influence of preoperative serum N-terminal pro-brain type natriuretic peptide on the postoperative outcome and survival rates of coronary artery bypass patients. Clinics (Sao Paulo) (2010) 0.93
Management of aortobronchial fistula developing 27 years after open aortic surgery by means of endovascular stent grafting. J Thorac Cardiovasc Surg (2009) 0.93
Leoligin, the major lignan from Edelweiss, inhibits intimal hyperplasia of venous bypass grafts. Cardiovasc Res (2009) 0.93
Surgical wound-healing complications in heart transplant recipients treated with rapamycin. Wound Repair Regen (2007) 0.93
CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis. Clin Transplant (2008) 0.92
Stent grafting of dissected descending aorta in patients with Marfan's syndrome: mid-term results. JACC Cardiovasc Interv (2008) 0.92
In vivo (animal) models of vein graft disease. Eur J Cardiothorac Surg (2006) 0.92
Aortic valve replacement in the conscious patient under regional anesthesia without endotracheal intubation. J Thorac Cardiovasc Surg (2003) 0.92
Secondary surgical interventions after endovascular stent-grafting of the thoracic aorta. Eur J Cardiothorac Surg (2004) 0.91
Axillary artery cannulation in surgery of the ascending aorta and the aortic arch. Eur J Cardiothorac Surg (2002) 0.91
Two-dimensional speckle-tracking strain echocardiography in long-term heart transplant patients: a study comparing deformation parameters and ejection fraction derived from echocardiography and multislice computed tomography. Eur J Echocardiogr (2011) 0.91
Perivascular application of C-type natriuretic peptide attenuates neointimal hyperplasia in experimental vein grafts. Eur J Cardiothorac Surg (2004) 0.90
Risk factors of mortality and permanent neurologic injury in patients undergoing ascending aortic and arch repair. J Thorac Cardiovasc Surg (2003) 0.89
Intraoperative iatrogenic type A aortic dissection and perioperative outcome. Interact Cardiovasc Thorac Surg (2005) 0.88
Minimally invasive thoratec Heartmate II implantation in the setting of severe thoracic aortic calcification. Ann Thorac Surg (2013) 0.88
Rapamycin treatment is associated with an increased apoptosis rate in experimental vein grafts. Eur J Cardiothorac Surg (2005) 0.87
Long-term results of thoracic endovascular aortic repair in atherosclerotic aneurysms involving the descending aorta. J Thorac Cardiovasc Surg (2010) 0.87
Treatment of destructive aortic valve endocarditis with the Freestyle Aortic Root Bioprosthesis. Ann Thorac Surg (2003) 0.87
Perivascular treatment with azathioprine reduces neointimal hyperplasia in experimental vein grafts. Heart Surg Forum (2006) 0.86
Emergency treatment of the thoracic aorta: results in 113 consecutive acute patients (the Talent Thoracic Retrospective Registry). Eur J Cardiothorac Surg (2008) 0.86
Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure. J Thorac Cardiovasc Surg (2006) 0.85
A rare case of primary cardiac B cell lymphoma. J Cardiothorac Surg (2014) 0.85
5-Methoxyleoligin, a lignan from Edelweiss, stimulates CYP26B1-dependent angiogenesis in vitro and induces arteriogenesis in infarcted rat hearts in vivo. PLoS One (2013) 0.85
Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up. Int J Cardiol (2005) 0.85
Stem cells and cardiac regeneration. Transpl Int (2007) 0.85
Aortic dissection after sildenafil-induced erection. South Med J (2006) 0.85
Transvenous pacemaker lead removal is safe and effective even in large vegetations: an analysis of 53 cases of pacemaker lead endocarditis. Pacing Clin Electrophysiol (2006) 0.84
Heterotopic tracheal transplantation with omentum wrapping in the abdominal position preserves functional and structural integrity of a human tracheal allograft. J Thorac Cardiovasc Surg (2004) 0.84
Lead contributes to arterial intimal hyperplasia through nuclear factor erythroid 2-related factor-mediated endothelial interleukin 8 synthesis and subsequent invasion of smooth muscle cells. Arterioscler Thromb Vasc Biol (2010) 0.83
A new mechanism by which an acute type B aortic dissection is primarily complicated, becomes complicated, or remains uncomplicated. Ann Thorac Surg (2012) 0.83
Aortic bioprosthetic valve deterioration 8 months after implantation. Ann Thorac Surg (2010) 0.83
Immunobiologic consequences of assist devices. Cardiol Clin (2003) 0.83
[2014 ESC/EACTS Guidelines on myocardial revascularization]. Kardiol Pol (2014) 0.83
Cadmium activates a programmed, lysosomal membrane permeabilization-dependent necrosis pathway. Toxicol Lett (2012) 0.83
An Evaluation of the Clinical Evidence on the Role of Inflammation and Oxidative Stress in Smoking-Mediated Cardiovascular Disease. Biomark Insights (2008) 0.83
Robotic totally endoscopic double-vessel bypass grafting: a further step toward closed-chest surgical treatment of multivessel coronary artery disease. Heart Surg Forum (2007) 0.82
Enhanced cell therapy for ischemic heart disease. Transplantation (2008) 0.82
Intrapulmonary shunt after cardiopulmonary bypass: the use of vital capacity maneuvers versus off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg (2002) 0.82
The influence of ascending aortic atherosclerosis on the long-term survival after CABG. Eur J Cardiothorac Surg (2005) 0.82
Bilateral lung transplantation with intra- and postoperatively prolonged ECMO support in patients with pulmonary hypertension. Eur J Cardiothorac Surg (2002) 0.81
Thoracic endovascular aortic repair in 300 patients: long-term results. Ann Thorac Surg (2013) 0.81
Identification and pharmacological characterization of the anti-inflammatory principal of the leaves of dwarf elder (Sambucus ebulus L.). J Ethnopharmacol (2010) 0.80
Endovascular repair of the descending aorta and the aortic arch with the Relay stent graft. Ann Thorac Surg (2009) 0.80
Robotic totally endoscopic coronary artery bypass and catheter based coronary intervention in one operative session. Ann Thorac Surg (2005) 0.80
Impact of surgical era on outcomes of patients undergoing elective atherosclerotic ascending aortic aneurysm operations. Eur J Cardiothorac Surg (2004) 0.80
A new exposure technique for the circumflex coronary artery system in robotic totally endoscopic coronary artery bypass grafting. Interact Cardiovasc Thorac Surg (2006) 0.80
Endovascular stent graft placement in patients with acute thoracic aortic syndromes. Eur J Cardiothorac Surg (2003) 0.79
Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure. Interact Cardiovasc Thorac Surg (2007) 0.79
Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients. Transplantation (2004) 0.79
Experimental stent-graft treatment of ascending aortic dissection. Ann Thorac Surg (2008) 0.79
Comparison of three-dimensional imaging to transesophageal echocardiography for preoperative evaluation in mitral valve prolapse. Am J Cardiol (2006) 0.79
Long-term results of CMV hyperimmune globulin prophylaxis in 377 heart transplant recipients. J Heart Lung Transplant (2003) 0.79